A bio-inspired investigation of the reactions of substrates of type 1 with VOF 3 and PIFA [phenyliodine(III) bis(trifluoroacetate)] led to a collection of colchicine-like compounds 2-5 and related systems. Biological evaluation revealed that some of the synthesized products had significant cytotoxic properties against the colon cancer cell line HT-29.
the synthesis of a library of bio-inspired compounds, and their biological evaluation as cytotoxic agents. Scheme 1 summarizes the postulated biosynthetic pathway leading from dopamine (I) and phenol aldehyde (II) to demecolcine (V) and thence colchicine (VI) via (S)-autumnaline (III) and (S)-isoandrocymbine (IV). The first two enzymatic transformations of (I + II to III) and (III to IV) are well understood as a Pictet-Spengler and an oxidative phenol-phenol coupling, respectively. 8 However, the conversion of isoandrocymbine to demecolcine and thence colchicine (IV to V and VI) is more complex and rather speculative (see Scheme 1) . 8 These complexities are reflected in the fact that a biomimetic total synthesis of colchicine still has not been reported. 6 Thus, while the non-enzymatic conversion of (I + II to III) has been demonstrated in the laboratory, not all the subsequent steps have been reported as yet by chemical means. 9 Our studies were, therefore, focused on finding conditions to realize useful pathways for the formation of colchicine-like structures and related scaffolds starting from substrates 1 (Figure 1 ), which are derivatives of autumnaline (III). The four possible tetracyclic structural motifs 2-5 were expected to be formed oxidatively from 1, as shown in Figure 1 (see color code). Scheme 2 summarizes the results of our investigations of the reaction of the readily available substrates 1a-f (synthesized by standard methods; see Supplementary data) 8,10 with VOF 3 -TFA-TFAA, an approach previously reported by Kupchan and coworkers. 10d, 11 At the outset of our work, the potential of this reaction to produce novel molecular diversity was still considered to be high because of the limited number of products and biological data reported by Kupchan et al. 10d, 11 Indeed, under two different sets of conditions [a) or b)] a variety of additional products were obtained as shown in Scheme 2. Thus, under conditions a) [VOF 3 , TFA-TFAA, CH 2 Cl 2 , 0-25 °C] several new compounds were isolated: 2a (22% yield from 1a); 8c (7% yield) plus 9c (6% yield) from 1c; 2d (17% yield) plus 7d′ (5% yield) plus 9d (7% yield) from 1d; 2e (46% yield) 10d,11 plus 11a (27% yield) from 1e; and 2f (< 2% yield) plus 7f (23% yield) 10d,12 plus 8f (< 2% yield) from 1f. At lower temperatures, conditions b) [−20 → 0 °C], the VOF 3 reaction yielded compounds 2a (22% yield) plus 9a (7% yield) plus 7a (< 2% yield, this compound was obtained in 17% yield under different conditions, see Scheme 2) from 1a; 2b (34% yield) plus 7b (7% yield, this compound was obtained in 19% yield under different conditions, see Scheme 2) from 1b; and 7e (11% yield) from 1e. 10d Since we were primarily interested in generating molecular diversity rather than any particular compound, no further attempts were made to improve the selectivity of this reaction.
Hoping to synthesize additional novel products from substrate 1e, we explored its reaction with VOF 3 under three additional sets of conditions [a), b) and c), Scheme 3]. Thus, treatment of 1e with VOF 3 [TFA-TFAA-CH 2 Cl 2 , 10:1:100, conditions a)] at 0-25 °C for 3 h furnished scaffolds 10a (9% yield) and 11a (17% yield). Carrying out the same reaction in neat TFA-TFAA [75:1, conditions b)] led to the isolation of 2e in 46% yield and 11a in 27 % yield. Modifying these conditions further [TFA-TFAA-CH 2 Cl 2 10:1:150 for 16 h, conditions c)] afforded 11a in 49% yield. Derivatives 11b-11j were prepared from 11a by standard procedures as summarized in Scheme 3. Compounds 10b and 11j′ were also formed as shown in Scheme 3, the latter as a major byproduct of the reaction of 11a with trifluoromethanesulfonic anhydride (Tf 2 O).
We then examined the reaction of substrates 1a-f with phenyliodine(III) bis(trifluoroacetate) (PIFA) 13 from which a number of new molecular scaffolds were isolated as shown in Scheme 4. Thus, exposure of tetrahydroisoquinolines 1a-f to PIFA in CH 2 Cl 2 at 0 → 25 °C led to products 3a (13% yield) from 1a; 3b (35% yield) from 1b; 3c (14% yield) plus oquinone 4c′ (9% yield) from 1c; 3d (5% yield) 9 plus 4d (7% yield) from 1d; 3e (8% yield) 10d,11 plus 3e′ (6% yield) plus 4e (< 2% yield) from 1e; and 3f (25% yield) from 1f. 8, 9, 12, 14 Changing the solvent from CH 2 Cl 2 to benzene and heating at 80 °C, the PIFA reaction with 1a-f mostly favors the formation of motif 4, producing 4a (12% yield) from 1a; 4b (< 2% yield) from 1b, among a complex mixture of other products; 4c (22% yield) from 1c; 4d (< 2% yield) from 1d; and 4e (10% yield) plus 3e (< 2% yield) plus 3e′ (< 2% yield) from 1e. Derivative 4e′ (83% yield) was prepared from 4e as indicated in Scheme 4. The formation of products 3a-f is presumed to proceed via either the addition-elimination pathway 13d,e (intermediate 12a) , or the phenoxenium ion pathway 13d,e (phenoxenium ion 12b and its resonance counterpart -carbenium ion 12c) as demonstrated in Scheme 4. The generation of compounds 4a-e is assumed to proceed through fleeting intermediates 12b, 12c and 12d (1,4- quinomethine) (Scheme 4).
Compounds 5a-e were prepared from isoquinoline 13 15 as summarized in Scheme 5. Thus, benzylation or methylation of 13 (K 2 CO 3 , BnBr or MeI) and subsequent reduction with lithium aluminum hydride (LAH) gave rather labile derivative 14a or 14b. Heating the latter compounds in the presence of HCOOH-H 3 PO 4 15 led, through presumed iminium species 15, to 5a (19% overall yield) from 13, 5c (38% overall yield) plus 5d (14% overall yield) from 13. Acetylation of 5a and 5d led to derivatives 5b (80% yield) and 5e (70% yield), respectively. Scheme 6 summarizes the reaction of isoquinoline 13 with PIFA leading, first to the previously mentioned (see Scheme 3) tetracyclic product 11a (11% yield), and thence to pentacyclic compound 17 (7% yield from 13). This process is believed to proceed through intermediates 16a, 16b, and 16c as depicted in Scheme 6.
Colchicine exerts its cytotoxic activity through tubulin binding that disturbs the tubulinmicrotubule equilibrium. 6 As we mentioned before, colchicine is highly potent against the colorectal adenocarcinoma cell line HT-29. The synthesized colchicinoid and related compounds were, therefore, assayed for cytotoxicity against HT-29 cancer cells using the MTT assay [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]. The so obtained IC 50 values are shown in Figure 2 , together with that found for colchicine (IC 50 ~ 0.01 µM) for comparison . Compounds 10a, 11a, 11b, 11e, 11f, 11g, and 11h exhibited the highest cytotoxic activity in this assay (IC 50 values = 0.132-0.684 µM, in red) . Compounds 2a, 2e,  4c′, 5a, 8c, 10b, 11c , and 11d exhibited lower potencies (IC 50 values = 0.99-9.10 µM, in blue), while the rest of the compounds showed either low activity (IC 50 values < 50 µM, in black) or their activity was not determined (n.d., in black).
The bio-inspired investigation of the reactions of autumnaline derivatives 1a-f led to a series of novel colchicine-related compounds. Biological evaluation of these compounds identified several agents with significant cytotoxicity against HT-29 cancer cells. Among them, the most potent ones were compounds 11a, 11b and 11e-11h . These results suggest these molecular scaffolds as leads for further studies aiming at new biological tools and potential therapies for the treatment of cancer.
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Figure 1.
Possible oxidative pathways depicted in retrosynthetic format to compounds 2-5 from substrates 1.
Figure 2.
Cytotoxicity of synthesized compounds against HT-29 cancer cells.a a HT-29 cells were grown in RPMI-1640 media supplemented with 10% newborn calf serum (NCS), and maintained at 37 °C with 5% CO 2 and 95% air. Cells were plated in a 96well plate (5 × 10 3 cells/well) 24 h prior to incubation with the indicated compound. The media was then replaced with fresh media containing varying concentrations of the indicated compound. Following a 96-hour incubation, MTT (5 mg/mL, 25 µL/well) was added and incubation was continued at 37 °C for 1-2 h (or until formazan crystals were visible in control wells). Media was carefully aspirated and DMSO was added (200 µL/well) to dissolve the purple MTT-formazan crystals. The absorbance of the dissolved formazan was quantified at 570 nm using UV-Vis plate reader and cell viability was determined as a fraction of absorbance relative to untreated control wells. Each experiment was performed in triplicate and individual data points are presented as averages +/− standard deviation. Figure  2 shows examples of compounds with high (IC 50 < 1 µM; red), medium (IC 50 < 10 µM; blue), low (IC 50 < 50 µM; black) and negligible (IC 50 more than 50 µM or n.d. = not determined) anti-HT-29 activity. Bn = benzyl; Bz = benzoyl; Cy = cyclohexyl; Troc = 2,2,2trichloroethoxycarbonyl; C(S)imid = thionoimidazolide; MTT = 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide.
Scheme 1.
Postulated biosynthesis of demecolcine (V) and colchicine (VI) from dopamine (I) and phenol aldehyde (II). Colors indicate atoms joining to form the corresponding C-C bond. The complex skeletal rearrangement from IV to V or VI can be found in Ref. 8.
→ 7d′ through C-ring expansion (see Supplementary data); [h] 8f can be formed from 1f with PIFA in refluxing benzene or via a skeletal rearrangement from 3f (Scheme 4) in the presence of a Lewis acid (BF 3 •Et 2 O in CH 2 Cl 2 ) or a protic acid (p-TsOH in AcOH) (see Supplementary data). TFA = 2,2,2-trifluoroacetic acid; TFAA = trifluoroacetic anhydride.
Scheme 6.
Reaction of isoquinoline 13 with PIFA. Preparation of compound 17 and proposed mechanism of its formation from 13 via 11a. Reagents and conditions: a) PIFA, CH 2 Cl 2 , 0 to 25 °C, 1 h, 11a (11%) plus 17 (7%). TFA = 2,2,2-trifluoroacetic acid.
